2023-01-012023-12-312023-12-31false11867659IHEALTH PHARMA LIMITED2024-08-1546460iso4217:GBPxbrli:pure118676592023-01-01118676592023-12-31118676592023-01-012023-12-31118676592022-01-01118676592022-12-31118676592022-01-012022-12-3111867659bus:SmallEntities2023-01-012023-12-3111867659bus:AuditExempt-NoAccountantsReport2023-01-012023-12-3111867659bus:FullAccounts2023-01-012023-12-3111867659bus:PrivateLimitedCompanyLtd2023-01-012023-12-3111867659core:WithinOneYear2023-12-3111867659core:AfterOneYear2023-12-3111867659core:WithinOneYear2022-12-3111867659core:AfterOneYear2022-12-3111867659core:ShareCapital2023-12-3111867659core:SharePremium2023-12-3111867659core:RevaluationReserve2023-12-3111867659core:OtherReservesSubtotal2023-12-3111867659core:RetainedEarningsAccumulatedLosses2023-12-3111867659core:ShareCapital2022-12-3111867659core:SharePremium2022-12-3111867659core:RevaluationReserve2022-12-3111867659core:OtherReservesSubtotal2022-12-3111867659core:RetainedEarningsAccumulatedLosses2022-12-3111867659core:LandBuildings2023-12-3111867659core:PlantMachinery2023-12-3111867659core:Vehicles2023-12-3111867659core:FurnitureFittings2023-12-3111867659core:OfficeEquipment2023-12-3111867659core:NetGoodwill2023-12-3111867659core:IntangibleAssetsOtherThanGoodwill2023-12-3111867659core:ListedExchangeTraded2023-12-3111867659core:UnlistedNon-exchangeTraded2023-12-3111867659core:LandBuildings2022-12-3111867659core:PlantMachinery2022-12-3111867659core:Vehicles2022-12-3111867659core:FurnitureFittings2022-12-3111867659core:OfficeEquipment2022-12-3111867659core:NetGoodwill2022-12-3111867659core:IntangibleAssetsOtherThanGoodwill2022-12-3111867659core:ListedExchangeTraded2022-12-3111867659core:UnlistedNon-exchangeTraded2022-12-3111867659core:LandBuildings2023-01-012023-12-3111867659core:PlantMachinery2023-01-012023-12-3111867659core:Vehicles2023-01-012023-12-3111867659core:FurnitureFittings2023-01-012023-12-3111867659core:OfficeEquipment2023-01-012023-12-3111867659core:NetGoodwill2023-01-012023-12-3111867659core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3111867659core:ListedExchangeTraded2023-01-012023-12-3111867659core:UnlistedNon-exchangeTraded2023-01-012023-12-3111867659core:MoreThanFiveYears2023-01-012023-12-3111867659core:Non-currentFinancialInstruments2023-12-3111867659core:Non-currentFinancialInstruments2022-12-3111867659dpl:CostSales2023-01-012023-12-3111867659dpl:DistributionCosts2023-01-012023-12-3111867659core:LandBuildings2023-01-012023-12-3111867659core:PlantMachinery2023-01-012023-12-3111867659core:Vehicles2023-01-012023-12-3111867659core:FurnitureFittings2023-01-012023-12-3111867659core:OfficeEquipment2023-01-012023-12-3111867659dpl:AdministrativeExpenses2023-01-012023-12-3111867659core:NetGoodwill2023-01-012023-12-3111867659core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3111867659dpl:GroupUndertakings2023-01-012023-12-3111867659dpl:ParticipatingInterests2023-01-012023-12-3111867659dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3111867659core:ListedExchangeTraded2023-01-012023-12-3111867659dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3111867659core:UnlistedNon-exchangeTraded2023-01-012023-12-3111867659dpl:CostSales2022-01-012022-12-3111867659dpl:DistributionCosts2022-01-012022-12-3111867659core:LandBuildings2022-01-012022-12-3111867659core:PlantMachinery2022-01-012022-12-3111867659core:Vehicles2022-01-012022-12-3111867659core:FurnitureFittings2022-01-012022-12-3111867659core:OfficeEquipment2022-01-012022-12-3111867659dpl:AdministrativeExpenses2022-01-012022-12-3111867659core:NetGoodwill2022-01-012022-12-3111867659core:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3111867659dpl:GroupUndertakings2022-01-012022-12-3111867659dpl:ParticipatingInterests2022-01-012022-12-3111867659dpl:GroupUndertakingscore:ListedExchangeTraded2022-01-012022-12-3111867659core:ListedExchangeTraded2022-01-012022-12-3111867659dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-01-012022-12-3111867659core:UnlistedNon-exchangeTraded2022-01-012022-12-3111867659core:NetGoodwill2023-12-3111867659core:IntangibleAssetsOtherThanGoodwill2023-12-3111867659core:LandBuildings2023-12-3111867659core:PlantMachinery2023-12-3111867659core:Vehicles2023-12-3111867659core:FurnitureFittings2023-12-3111867659core:OfficeEquipment2023-12-3111867659core:AfterOneYear2023-12-3111867659core:WithinOneYear2023-12-3111867659core:ListedExchangeTraded2023-12-3111867659core:UnlistedNon-exchangeTraded2023-12-3111867659core:ShareCapital2023-12-3111867659core:SharePremium2023-12-3111867659core:RevaluationReserve2023-12-3111867659core:OtherReservesSubtotal2023-12-3111867659core:RetainedEarningsAccumulatedLosses2023-12-3111867659core:NetGoodwill2022-12-3111867659core:IntangibleAssetsOtherThanGoodwill2022-12-3111867659core:LandBuildings2022-12-3111867659core:PlantMachinery2022-12-3111867659core:Vehicles2022-12-3111867659core:FurnitureFittings2022-12-3111867659core:OfficeEquipment2022-12-3111867659core:AfterOneYear2022-12-3111867659core:WithinOneYear2022-12-3111867659core:ListedExchangeTraded2022-12-3111867659core:UnlistedNon-exchangeTraded2022-12-3111867659core:ShareCapital2022-12-3111867659core:SharePremium2022-12-3111867659core:RevaluationReserve2022-12-3111867659core:OtherReservesSubtotal2022-12-3111867659core:RetainedEarningsAccumulatedLosses2022-12-3111867659core:NetGoodwill2022-01-0111867659core:IntangibleAssetsOtherThanGoodwill2022-01-0111867659core:LandBuildings2022-01-0111867659core:PlantMachinery2022-01-0111867659core:Vehicles2022-01-0111867659core:FurnitureFittings2022-01-0111867659core:OfficeEquipment2022-01-0111867659core:AfterOneYear2022-01-0111867659core:WithinOneYear2022-01-0111867659core:ListedExchangeTraded2022-01-0111867659core:UnlistedNon-exchangeTraded2022-01-0111867659core:ShareCapital2022-01-0111867659core:SharePremium2022-01-0111867659core:RevaluationReserve2022-01-0111867659core:OtherReservesSubtotal2022-01-0111867659core:RetainedEarningsAccumulatedLosses2022-01-0111867659core:AfterOneYear2023-01-012023-12-3111867659core:WithinOneYear2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:CostValuation2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3111867659core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3111867659core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3111867659core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3111867659core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3111867659core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3111867659core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3111867659core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3111867659core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3111867659core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3111867659core:Non-currentFinancialInstrumentscore:CostValuation2022-12-3111867659core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-3111867659core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-3111867659core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-3111867659core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-3111867659core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-3111867659core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-3111867659core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-3111867659core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-3111867659bus:Director12023-01-012023-12-31

IHEALTH PHARMA LIMITED

Registered Number
11867659
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2023

IHEALTH PHARMA LIMITED
Company Information
for the year from 1 January 2023 to 31 December 2023

Director

KAUTE, Daniel Alfred Wilhelm, Dr.

Registered Address

C/O Srm, 59
Terrington Hill
Marlow
SL7 2RE

Registered Number

11867659 (England and Wales)
IHEALTH PHARMA LIMITED
Balance Sheet as at
31 December 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Investments3150,000150,000
150,000150,000
Current assets
Cash at bank and on hand9,5811
9,5811
Prepayments and accrued income355-
Creditors amounts falling due within one year5(162,037)(160,597)
Net current assets (liabilities)(152,101)(160,596)
Total assets less current liabilities(2,101)(10,596)
Net assets(2,101)(10,596)
Capital and reserves
Called up share capital15,0011
Profit and loss account(17,102)(10,597)
Shareholders' funds(2,101)(10,596)
The financial statements were approved and authorised for issue by the Director on 15 August 2024, and are signed on its behalf by:
KAUTE, Daniel Alfred Wilhelm, Dr.
Director
Registered Company No. 11867659
IHEALTH PHARMA LIMITED
Notes to the Financial Statements
for the year ended 31 December 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20232022
Average number of employees during the year00
3.Fixed asset investments

Other investments1

Total

££
Cost or valuation
At 01 January 23150,000150,000
At 31 December 23150,000150,000
Net book value
At 31 December 23150,000150,000
At 31 December 22150,000150,000

Notes

1Other investments other than loans
4.Debtors: amounts due within one year
5.Creditors: amounts due within one year

2023

2022

££
Amounts owed to related parties162,037160,597
Total162,037160,597